Skip to search formSkip to main contentSkip to account menu

CBM 4A

Known as: CBM-4A 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

chlorobromofosfamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Activity and Distribution of Cells Infiltrating TC-1 Tumours after Chemotherapy and Subsequent IL-12 Immunotherapy
Methods: Moderately immunogenic HPV-16-associated TC-1 tumour mimicking human HPV-16-associated neoplasms was used to examine the… 
2007
2007
CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours.
Oligodeoxynucleotides containing guanine-cytidine dimers (CpG ODN) are potent inducers of anti-tumour immune responses. In this… 
1994
1994
Pharmacological properties of racemic chlorobromofosfamide.
Racemic chlorobromofosfamide (CBM-4A) is a bromine substituted analog of ifosfamide. The studies reported here were aimed at… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)